Experimental depletion of CD8+ T cells in animal models improves NASH and NASH-associated HCC, restoring hepatic insulin sensitivity, decreased liver damage, and reduced fibrosis [186]. This evidence concerns the gene CD8A and metabolic dysfunction-associated steatohepatitis.